FDA Authorizes First Wearable Device That Monitors Ketone and Glucose Levels
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
Summary
The FDA has approved the Libre Duo, a continuous monitoring system that tracks both glucose and ketone levels, aimed at improving diabetes management for individuals aged 2 and up. This dual functionality could enhance how patients monitor their condition and make informed health decisions.
Comments (236 of ) ⌛